IMC 3.85% 7.5¢ immuron limited

On U.S. market, Innovate Pharmaceuticals (INNT), looking to...

  1. 928 Posts.
    lightbulb Created with Sketch. 61
    On U.S. market, Innovate Pharmaceuticals (INNT), looking to enter P3 in Celiac's disease, trading at $625,000,000 market cap (25+M shares outstanding). $IMRN entering P3 in NASH, 3.6M shares, $40,000,000 MC.
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
-0.003(3.85%)
Mkt cap ! $17.18M
Open High Low Value Volume
7.7¢ 7.7¢ 7.5¢ $5.59K 73.54K

Buyers (Bids)

No. Vol. Price($)
2 16083 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 6857 1
View Market Depth
Last trade - 15.31pm 05/11/2024 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.